美股新聞 標題聯播 · 近 24 小時 294 則 · 33 個來源 · 最新 9/20 03:26
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · VRTX近 30 天 17 則 · 第 1 / 1 頁
- Vertex Pharmaceuticals (VRTX) Stock Sinks As Market Gains: Here's Why
- 2 Reasons to Like VRTX (and 1 Not So Much)
- Is This Biotech Stock Too Cheap to Ignore After Its Latest Pullback?
- Where Will CRISPR Therapeutics Be in 10 Years if Gene Editing Fulfills Its Promise?
- Vortex Energy 簽訂資產購買協議 收購薩斯喀徹溫省的 Meadows 項目Vortex Energy Enters Into Asset Purchase Agreement to Acquire the Meadows Project in Saskatchewan
- 基因編輯巨頭及其競爭對手飆升 邁向突破Gene-Editing Powerhouse And Its Rivals Surge Toward A Breakout
- SION to Cut Workforce by Nearly Half After CF Study Failure, Stock Down
- Vera Reverses Its Major Chart Upset As Vertex Rivalry Deepens — What Happened?
- Will Vertex’s (VRTX) New CFO Elevation and Digital Focus Reframe Its Capital Allocation Narrative?
- Vertex Pharmaceuticals (VRTX), Why Is It Getting Fresh Attention Now?
- Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial Results
- 1 Unpopular Stock That Should Get More Attention and 2 We Brush Off
- Vortex Energy Engages Lonquist to Manage Ground Gravity Survey at the Robinsons River Salt Project
- Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?
- Vertex Pharmaceuticals Incorporated (VRTX): Crinetics Acquisition Creates a New Growth Engine Beyond Cystic Fibrosis
- Strong Core Business, Raised Guidance Push Vertex Pharmaceuticals Higher
- Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。